JP6660291B2 - ニーマン・ピック病の診断のための方法 - Google Patents

ニーマン・ピック病の診断のための方法 Download PDF

Info

Publication number
JP6660291B2
JP6660291B2 JP2016513253A JP2016513253A JP6660291B2 JP 6660291 B2 JP6660291 B2 JP 6660291B2 JP 2016513253 A JP2016513253 A JP 2016513253A JP 2016513253 A JP2016513253 A JP 2016513253A JP 6660291 B2 JP6660291 B2 JP 6660291B2
Authority
JP
Japan
Prior art keywords
niemann
subject
biomarker
pick disease
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2016513253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016522406A5 (cg-RX-API-DMAC7.html
JP2016522406A (ja
Inventor
アーント ロルフス
アーント ロルフス
ヘルマン マスケル
ヘルマン マスケル
Original Assignee
セントジーン アーゲー
セントジーン アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セントジーン アーゲー, セントジーン アーゲー filed Critical セントジーン アーゲー
Publication of JP2016522406A publication Critical patent/JP2016522406A/ja
Publication of JP2016522406A5 publication Critical patent/JP2016522406A5/ja
Priority to JP2020019691A priority Critical patent/JP6989636B2/ja
Application granted granted Critical
Publication of JP6660291B2 publication Critical patent/JP6660291B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00Particle spectrometers or separator tubes
    • H01J49/0027Methods for using particle spectrometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04Phospholipids, i.e. phosphoglycerides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2016513253A 2013-05-14 2014-05-14 ニーマン・ピック病の診断のための方法 Expired - Fee Related JP6660291B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020019691A JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13002515.8 2013-05-14
EP13002515 2013-05-14
PCT/EP2014/001306 WO2014183873A1 (en) 2013-05-14 2014-05-14 Method for the diagnosis of niemann-pick disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020019691A Division JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Publications (3)

Publication Number Publication Date
JP2016522406A JP2016522406A (ja) 2016-07-28
JP2016522406A5 JP2016522406A5 (cg-RX-API-DMAC7.html) 2017-06-08
JP6660291B2 true JP6660291B2 (ja) 2020-03-11

Family

ID=48428310

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016513253A Expired - Fee Related JP6660291B2 (ja) 2013-05-14 2014-05-14 ニーマン・ピック病の診断のための方法
JP2020019691A Expired - Fee Related JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020019691A Expired - Fee Related JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Country Status (10)

Country Link
US (1) US10302664B2 (cg-RX-API-DMAC7.html)
EP (1) EP2997384B1 (cg-RX-API-DMAC7.html)
JP (2) JP6660291B2 (cg-RX-API-DMAC7.html)
CA (1) CA2912274A1 (cg-RX-API-DMAC7.html)
CY (1) CY1121790T1 (cg-RX-API-DMAC7.html)
DK (1) DK2997384T3 (cg-RX-API-DMAC7.html)
ES (1) ES2731920T3 (cg-RX-API-DMAC7.html)
SA (1) SA515370129B1 (cg-RX-API-DMAC7.html)
TR (1) TR201906195T4 (cg-RX-API-DMAC7.html)
WO (1) WO2014183873A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3004896B1 (en) * 2013-06-07 2019-09-18 Genzyme Corporation Marker for acid sphingomyelinase disorders and uses thereof
AU2015349030A1 (en) * 2014-11-19 2017-05-04 Centogene Gmbh Method for the diagnosis of Niemann-Pick disease using a biomarker
JP7568648B2 (ja) * 2019-05-31 2024-10-16 ジェンザイム・コーポレーション 二次元lc-ms/msシステム

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
EP1616193B1 (en) * 2003-03-31 2012-03-21 Women's And Children's Hospital MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs)
JP2007514661A (ja) * 2003-11-25 2007-06-07 マウント シナイ スクール オブ メディスン オブ ニューヨーク ユニバーシティー ニーマンピック病のシャペロンに基づく治療方法
KR20090006837A (ko) * 2006-03-24 2009-01-15 페노미넘 디스커버리스 인코포레이티드 전립선 암 진단용 생물표지자 및 그의 제조방법
US8497122B2 (en) 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
PL2470199T3 (pl) * 2009-08-28 2019-11-29 Icahn School Med Mount Sinai Enzymatyczna terapia zastępcza ze zwiększaniem dawki do leczenia niedoboru kwaśnej sfingomielinazy

Also Published As

Publication number Publication date
CY1121790T1 (el) 2020-07-31
ES2731920T3 (es) 2019-11-19
EP2997384A1 (en) 2016-03-23
SA515370129B1 (ar) 2019-11-18
JP6989636B2 (ja) 2022-01-05
US20160109470A1 (en) 2016-04-21
JP2020101554A (ja) 2020-07-02
US10302664B2 (en) 2019-05-28
CA2912274A1 (en) 2014-11-20
WO2014183873A1 (en) 2014-11-20
TR201906195T4 (tr) 2019-05-21
JP2016522406A (ja) 2016-07-28
DK2997384T3 (da) 2019-07-22
EP2997384B1 (en) 2019-04-10

Similar Documents

Publication Publication Date Title
AU2021204429B2 (en) Method for the diagnosis of niemann-pick disease
JP6514256B2 (ja) ゴーシェ病の診断のための方法
JP6989636B2 (ja) ニーマン・ピック病の診断のための方法
US20200284806A1 (en) Method for the Diagnosis of Metachromatic Leukodystrophy
JP2017538927A (ja) バイオマーカーを用いたニーマン・ピック病の診断のための方法

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170419

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170419

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180308

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180530

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180731

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190802

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200108

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200207

R150 Certificate of patent or registration of utility model

Ref document number: 6660291

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees